4.6 Article

Directed Evolution of a Mycobacteriophage

Journal

ANTIBIOTICS-BASEL
Volume 8, Issue 2, Pages -

Publisher

MDPI
DOI: 10.3390/antibiotics8020046

Keywords

phage therapy; Mycobacterium smegmatis; mycobacteriophages; directed evolution

Funding

  1. Spanish Ministerio de Ciencia, Innovacion y Universidades (MCIU) [BFU2017-84762-R]
  2. European Research Council (ERC) [724519-Vis-a-vis]
  3. Juan de la Cierva Incorporacion contract from MCIU

Ask authors/readers for more resources

Bacteriophages represent an alternative strategy to combat pathogenic bacteria. Currently, Mycobacterium tuberculosis infections constitute a major public health problem due to extensive antibiotic resistance in some strains. Using a non-pathogenic species of the same genus as an experimental model, Mycobacterium smegmatis, here we have set up a basic methodology for mycobacteriophage growth and we have explored directed evolution as a tool for increasing phage infectivity and lytic activity. We demonstrate mycobacteriophage adaptation to its host under different conditions. Directed evolution could be used for the development of future phage therapy applications against mycobacteria.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available